MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023
Doug Doerfler, President and CEO, to Retire Effective December 31, 2023; will continue to serve as an advisor to MaxCyte...
Read moreDoug Doerfler, President and CEO, to Retire Effective December 31, 2023; will continue to serve as an advisor to MaxCyte...
Read moreATCHISON, Kan., Dec. 11, 2023 (GLOBE NEWSWIRE) -- MGP Ingredients, Inc. (Nasdaq: MGPI), a leading provider of distilled spirits, branded spirits,...
Read moreSAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on...
Read moreStadion receives recognition for the fifth consecutive yearWATKINSVILLE, Ga., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Stadion Money Management, which works...
Read moreDALLAS, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company...
Read moreNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of EHang...
Read moreNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of The Estée...
Read moreNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Did you own shares of National Instruments Corporation? Did...
Read moreNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Microvast...
Read moreThis free, in-person event will be held in partnership with Banner Health and Banner|Aetna AJMC is pleased to announce an...
Read more